Article: UC Berkeley Center for the Science of Psychedelics – Psychedelics and the Law
Cannabis Law Report
AUGUST 7, 2022
As more and more scientific research supports the therapeutic and medicinal potential of psychedelics, states and cities have begun to make these substances more accessible. In 2018, the FDA granted COMPASS Pathways BTD to develop psilocybin therapy for treatment-resistant depression. Where Laws Are Changing.
Let's personalize your content